Over 260 million people in the US—more than 77% of the population—will watch over-the-top (OTT) video this year, according to a March ĢAV forecast. Of these, nearly all will be watching YouTube.
Two-thirds of US retail media buyers expect to spend more on video advertising over the next 12 months, according to March 2025 data from Koddi. Nearly as many (63%) will up their investments in social media.
Consumers aren’t just looking for deals—they’re looking for brands they can trust. Nearly 80% of consumers say they’d be more likely to try a new retailer if it appeared in their bank’s rewards program, according to a new report from ĢAV and Chase Media Solutions.
The trend: Instagram is gaining momentum across Asia-Pacific, fueled by India’s 2020 TikTok ban and a projected 10% user growth in that market for 2025. Japan’s forecast has also climbed, with 44.4 million users expected next year. Our take: Instagram’s rise isn’t just reactive—it’s a sign of strong localization and feature depth. With TikTok facing stricter laws in Australia and Southeast Asia, Instagram’s Reels and group-channel tools position it as the more stable, advertiser-friendly option. Brands targeting APAC should reevaluate platform strategies as Instagram captures more of the region’s fast-changing digital attention.
In the first half of 2025, tariffs rattled retailers, consumer trust wavered in the face of muted DEI efforts, and fast-fashion platforms like Shein and Temu braced for policy whiplash. Meanwhile, private label products surged in popularity, and the retail world took a closer look at generative AI—not just for buzz, but for tangible impact across the shopper journey. Here are the top stories from H1 2025 and why they matter for the rest of the year.
Believe it or not, the year is already halfway over. For advertisers, it's been a whirlwind with economic upheaval, massive AI adoption, Google upending search, and working hard to understand Gen Z. Oh, and remember when TikTok went dark for a weekend?
The news: Brazil’s central bank rolled out a recurring payments feature to the Pix instant payment system, according to a report from Reuters. Our take: Pix’s use likely can keep growing steadily if it can target new volume opportunities.
E.l.f. SKIN is blending product marketing and comedy with “Sunhinged,” a comedy special that doubles as a PSA for sun protection.
The news: Prescription drug approval timelines will shrink under an FDA pilot program that will reduce the approval timelines from a typical 10 months to just 1 to 2 months. Our take: Speedier reviews and new AI programs for drug developers are good ideas, but pharma companies should remember the COVID-19 vaccines speed-to-market backlash and weigh the time benefit against whether their drugs will gain trust with physicians and patients.
The trend: Women see and hear more health-related information than men, especially when it comes to weight loss drugs and anti-aging treatments. Our take: Pharma and healthcare marketers need to more effectively reach women. Instead of marketing to all women, market to mindsets like self-care via social media influencers’ tips and advice, or motivations like caregiving and prevention by tapping into mammogram screening advocacy and resources that support overburdened women who care for loved ones.
The news: US adults are increasingly dependent on digital platforms for news, with social media and video overtaking traditional news outlets for the first time. 54% of US adults get their news from social media, per the Reuters Institute’s 2025 Digital News Report, compared with 50% from TV news and 48% from news websites and apps. Our take: Linear platforms could offer personalized news digests and mobile- and social- friendly content to reengage younger users, while advertisers should diversify their campaigns across social media platforms to follow fragmented user engagement.
The news: Podcasts are becoming a popular way for brands to reach engaged audiences, with viewership mounting and new platforms throwing their hats in the ring. Podcast viewership is thriving, reaching over 140 million US listeners in 2025, according to our forecast. Listeners will surpass 150 million by 2027. Our take: Podcasts are shaping up to become a strong contender in media consumption, with nearly 70% of US adults ages 18 to 24 listening at least one per month, per our forecast. As platforms battle to be the leading home for podcasts, advertisers need to pay attention and tailor strategies.
On today’s podcast episode, we discuss how retailers are approaching their DEI initiatives under the current administration, the impact of staying quiet this Pride Month, and where the discussion around DEI goes next. Listen to the conversation with our Senior Analyst Sara Lebow as she hosts Principal Analyst Sky Canaves, Analyst Paola Flores-Marquez, and Dr. Marcus Collins—author and Professor of Marketing at the Ross School of Business at the University of Michigan.
The news: Amazon CEO Andy Jassy said AI-driven efficiencies will reduce the company’s headcount. “As we roll out more generative AI and agents …we will need fewer people doing some of the jobs that are being done today, and more people doing other types of jobs,” Jassy said in a letter to employees. “In the next few years, we expect that this will reduce our total corporate workforce.” Our take: Companies that pursue an AI-first mission by laying off employees risk lower team morale, a resistance to AI adoption among workers, and damaged consumer trust. Still, Amazon’s scale, deep pockets, and cloud infrastructure dominance may insulate it from backlash or major fallout.
68% of US LGBTQ+ adults say all or most companies participate in Pride Month to boost business, while just 16% believe it’s driven by genuine support, per a January survey from Pew Research Center.
Cannes Lions, an annual opportunity for advertisers to score accolades for their creativity, is refining its agenda to acknowledge how that work drives business.
The news: Sovos will automate Shopify’s sales tax returns process for merchants. Our take: Reclaiming time and reducing risk for merchants helps position Shopify as a stronger commerce platform and partner.
The data: Nearly two-thirds of US adults (64%) have an unfavorable view of the House’s One Big Beautiful Bill Act, per KFF polling. Our take: If they aren’t already, healthcare marketers ought to be launching blitz campaigns about the bill’s potential ramifications. For instance, they could put pressure on lawmakers in the Senate by citing just-released study estimates that the proposed changes to Medicaid may result in ~25,000 preventable deaths annually due to how many patients will lose their physician, forgo needed medications, and put off screenings like mammograms.
The news: Anne Wojcicki, the co-founder and CEO of 23andMe, is set to recoup control of the company after outbidding Regeneron Pharmaceuticals in a bankruptcy action. Our take: 23andMe will have a brand reputation problem assuming Wojcicki regains control. The company’s best path forward, considering past mistakes, is tapping into new consumer health and wellness categories rather than enterprise partnerships with pharma.
The news: Novo Nordisk missed an important patent filing deadline in Canada for its weight loss and diabetes drug semaglutide, opening the door to generics as soon as next year. Our take: If Sandoz and other generic makers start selling semaglutide GLP-1 drugs in Canada next year, FDA approval for states may not matter. If drugmakers do start selling generic GLP-1s in Canada, Novo will see Ozempic brand sales drop, but the GLP-1 market could see a generics’ explosion.